Treace Medical Concepts, Inc. (“Treace” or the “Company”)
(NasdaqGS: TMCI), a medical technology company driving a
fundamental shift in the surgical treatment of bunions and related
midfoot deformities through its flagship Lapiplasty® and
Adductoplasty® Procedures, today announced that 100,000 patients
have been treated with its patented Lapiplasty® 3D Bunion
Correction® System.1 This milestone coincides with the
first-ever National Bunion Day in the United States, which is being
sponsored by Treace on April 16, 2024, and the launch of its new
patient education and brand awareness campaign.
“Achieving this important milestone is a
testament to the tireless efforts of our team members and the trust
of our surgeon customers and patients, all of whom have made our
journey possible,” said John T. Treace, CEO and Founder of Treace.
“Since our initial surgical cases in 2015, Treace has been
committed to educating people about surgical options that can
provide lasting relief from bunion pain through our innovative
procedures that are designed to minimize recovery time, reduce
recurrence rates, and improve patient outcomes. We look forward to
reaching even more people during National Bunion Day and raising
awareness of the impact that effective bunion treatment can have on
the quality of life for patients through our new patient outreach
efforts.”
A bunion is a complex bone deformity that
results from an unstable joint in the midfoot.2 While many
believe they are caused by wearing high heels or narrow shoes,
bunions affect both men and women of all ages and are often caused
by genetic factors.2,3 Bunion deformities are progressive and may
lead to arthritis, hammertoes, bone spurs, pain, swelling and
numbness that may have a significant impact on mobility and quality
of life.2,4
“When I started diving during my freshman year,
I told my parents and coaches that I couldn’t do four years of this
because of the pain I was in,” said Lauren, a patient who underwent
the Lapiplasty® Procedure to correct bunions on both of her feet.
“It was frustrating and depressing to think that there might never
be a way to fix my feet. I just wanted to be able to walk and train
without worrying about them. The chronic pain really took a toll on
me.” Since her procedures, Lauren is back to training and diving
every day. When asked about how the Lapiplasty® Procedure has
changed her life, Lauren remarks, “Being able to wear heels, or
really any shoe, longer than for an hour, walk or run for longer
periods of time, and practice without chronic foot pain has made a
world of difference. I never thought I would be able to do
that.”5
The Lapiplasty® Procedure allows surgeons to
correct all three planes of the bunion deformity and address its
root cause by securing the unstable joint in the middle of the foot
using a patented combination of instruments, implants and surgical
methods. By providing a comprehensive, 3D correction of the bunion
deformity, the Lapiplasty® Procedure allows most patients to
quickly return to bearing weight in a surgical boot within two
weeks after surgery and get back to their active lifestyle with a
low recurrence rate of only 0.9% to 3.2% as demonstrated in studies
at 17- and 13-months follow-up, respectively.6,7
National Bunion Day – April 16,
2024
In addition to recognizing this significant
company milestone, Treace will host a variety of events leading up
to National Bunion Day, which will be celebrated annually on the
third Tuesday in April. The Company plans to host online events,
provide new educational materials and sponsor opportunities for
patients to share their experiences with bunion pain and their
recovery journeys.
Updates on activities planned for National
Bunion Day will be available on the official National Bunion Day
webpage at www.lapiplasty.com/NationalBunionDay.
Latest Patient Education and Brand
Awareness Campaign
Today the Company also unveiled its latest
campaign to continue to drive patient education and awareness of
its Lapiplasty® Procedure. This new campaign, called “Future You,”
features TV, radio, social, and digital ads designed to elevate
education and engagement among patients who suffer from
lifestyle-limiting bunion pain.
Treace will premiere the “Future You” commercial
on the finale of “The Bachelor” TV show on March 25, 2024 at 8:00
p.m. Eastern Time on the ABC network.
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. All statements other than statements of
historical fact are forward-looking statements, including, but not
limited to, the Company’s expectations that it will reach even more
people during National Bunion Day and raise awareness of the impact
that effective bunion treatment can have on the quality of life for
patients. Forward-looking statements are based on management’s
current assumptions and expectations of future events and trends,
which affect or may affect the Company’s business, strategy,
operations or financial performance, and actual results and other
events may differ materially from those expressed or implied in
such statements due to numerous risks and uncertainties.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted or quantified.
Factors that could cause actual results or other events to differ
materially from those contemplated in this press release can be
found in the Risk Factors section of Treace’s public filings with
the Securities and Exchange Commission (SEC), including its Annual
Report on Form 10-K for the year ended December 31, 2023, and its
subsequent SEC filings. Because forward-looking statements are
inherently subject to risks and uncertainties, you should not rely
on these forward-looking statements as predictions of future
events. These forward-looking statements speak only as of their
date and, except to the extent required by law, the Company
undertakes no obligation to update these statements, whether as a
result of any new information, future developments or
otherwise.
Internet Posting of
Information
Treace routinely posts information that may be
important to investors in the “Investor Relations” section of its
website at www.treace.com. The Company encourages investors and
potential investors to consult the Treace website regularly for
important information about Treace.
About Treace Medical
Concepts
Treace Medical Concepts, Inc. is a medical
technology company with the goal of advancing the standard of care
for the surgical management of bunion and related midfoot
deformities. Bunions are complex 3-dimensional deformities that
originate from an unstable joint in the middle of the foot and
affect approximately 67 million Americans, of which Treace
estimates 1.1 million are annual surgical candidates. Treace has
pioneered and patented the Lapiplasty® 3D Bunion
Correction® System – a combination of instruments, implants,
and surgical methods designed to surgically correct all three
planes of the bunion deformity and secure the unstable joint,
addressing the root cause of the bunion and helping patients get
back to their active lifestyles. To further support the needs of
bunion patients, Treace has introduced its
Adductoplasty® Midfoot Correction System, designed for
reproducible surgical correction of the midfoot as well as its
Hammertoe PEEK Fixation System designed to address hammertoe, claw
toe and mallet toe deformities. The Company continues to expand its
footprint in the foot and ankle market with the introduction of its
SpeedPlate™ Rapid Compression Implants, an innovative fixation
platform with broad versatility across Lapiplasty® and
Adductoplasty® procedures, as well as other common bone fusion
procedures of the foot. For more information, please visit
www.treace.com.
To learn more about Treace, connect with us on
LinkedIn, Twitter, Facebook and Instagram.
1TMC Data on File2 American College of Foot and
Ankle Surgeons (ACFAS) Website3 WebMD Website4 American Academy of
Orthopedic Surgeons (AAOS) Website5 Only a surgeon can tell if the
Lapiplasty® Procedure is right for you. As with any medical
treatment, individual results
may vary. This experience is unique and specific to the patient.
For information about benefits, risks, and recovery,
visit www.lapiplasty.com.6 Dayton P, et al. J Foot Ankle Surg.
2019. 58:427-433. 7 Ray J, et al. Foot Ankle Int. 2019
Aug;40(8):955-960.
Contacts:
Treace Medical Concepts,
Inc.
Julie Dewey, IRCChief Communications &
Investor Relations Officerjddewey@treace.com | 209-613-6945
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/f2346867-3815-41b6-b57d-aba7cc910ba1
https://www.globenewswire.com/NewsRoom/AttachmentNg/a1428d79-95e9-4e16-9e27-886272b1848e
https://www.globenewswire.com/NewsRoom/AttachmentNg/23959a30-97e3-4f68-ab0e-de8b51fd207d
https://www.globenewswire.com/NewsRoom/AttachmentNg/11a3693e-21bb-45d3-9b5e-e5f280e6d824
Treace Medical Concepts (NASDAQ:TMCI)
Historical Stock Chart
From Apr 2024 to May 2024
Treace Medical Concepts (NASDAQ:TMCI)
Historical Stock Chart
From May 2023 to May 2024